Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Investrend Communications was a financial communications and investor relations firm that provided independent equity research and media services, primarily for small-cap and micro-cap companies. The company was best known for its Investrend Research division, which aimed to provide unbiased financial analysis to the investment community. While the firm served a diverse range of industries, it frequently worked with clients in the biotechnology and healthcare sectors to improve their visibility among investors. Investrend was a pioneer in establishing ethical standards for company-sponsored research to mitigate conflicts of interest. The company's operations effectively ceased after the death of its founder and CEO, Gayle Essary, in 2015.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investrend Communications.